Milestone Scientific (MLSS) Cash & Equivalents (2010 - 2026)

Milestone Scientific's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 46.83% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 46.83% YoY), while the FY2025 annual figure was $1.1 million, down 65.85% from the prior year.
• Cash & Equivalents came in at $1.2 million for Q1 2026 at Milestone Scientific, up from $1.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $13.3 million in Q1 2022 to a low of $1.1 million in Q4 2025.
• A 5-year average of $4.6 million and a median of $3.3 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 82.81% in 2023 and surged 120.01% in 2024, its largest moves.
• Milestone Scientific's Cash & Equivalents stood at $8.7 million in 2022, then plunged by 65.83% to $3.0 million in 2023, then increased by 9.41% to $3.3 million in 2024, then sank by 65.85% to $1.1 million in 2025, then increased by 7.35% to $1.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.2 million, $1.1 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison